Skip to main content
BML, INC. logo

BML, INC. — Investor Relations & Filings

Ticker · 4694 ISIN · JP3799700004 LEI · 5493003Y6Y1P8HBEL806 T Human health and social work activities
Open in API
Filings indexed 80 across all filing types
Latest filing 2026-03-16 Annual Report
Country US United States of America
Listing T 4694

About BML, INC.

https://www.bml.co.jp/eng/

BML, Inc. is a provider of comprehensive laboratory testing services and medical information systems. The company's core business is contract clinical testing for medical institutions, offering a wide range of laboratory analyses. These services span from routine biochemical and hematological tests to specialized areas such as microbiological, genome-related, and tumor marker testing. In addition to its laboratory operations, BML develops and provides medical informatics solutions, including software for clinical testing. The company operates an extensive network of laboratories to process samples and report results to customers in the medical field.

Recent filings

Filing Released Lang Actions
訂正有価証券報告書－第68期(2022/04/01－2023/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under Article 24, Paragraph 1 of the Financial Instruments and Exchange Act. It covers a full fiscal year (2022-04-01 to 2023-03-31) and contains extensive XBRL tagging for financial statements, which is characteristic of a comprehensive annual filing. FY 2023
2026-03-16 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. This specific document type is a mandatory attachment to an Annual Securities Report (Yukashoken Hokokusho) where the CEO confirms the accuracy of the report's contents. Since it is a regulatory filing required by law that does not fit into the primary financial report categories (like 10-K or IR) and is not an announcement of a report, it falls under the general regulatory filings category.
2026-03-16 Japanese
訂正有価証券報告書－第67期(2021/04/01－2022/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yukashoken Hokokusho' (Securities Report), which is the Japanese equivalent of an Annual Report (10-K). The header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act, covering the fiscal year from April 1, 2021, to March 31, 2022. It contains XBRL tags and detailed financial disclosure metadata, confirming it is the full annual filing rather than an announcement or summary. FY 2022
2026-03-16 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It serves as a formal certification by the CEO regarding the accuracy of the company's Annual Securities Report (Yukashoken Hokokusho). Since it is a regulatory filing required by law to accompany financial reports but does not constitute the financial report itself, and does not fit into specific categories like AGM or M&A, it is classified as a general regulatory filing.
2026-03-16 Japanese
訂正有価証券報告書－第66期(2020/04/01－2021/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yukashoken Hokokusho' (Annual Securities Report), which is the Japanese equivalent of a 10-K. The header explicitly identifies it as an 'Annual Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). It contains detailed financial data, business information, and XBRL tags for the fiscal year ending March 31, 2021. Although it mentions a correction report date in 2026, the document itself is the primary annual financial filing. FY 2021
2026-03-16 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a report (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements. H1 71
2025-11-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.